In malignancy, Uyttenhove et al (2003) demonstrated for the first time that IDO was expressed in various human cancer tissues, and that IDO was involved in protecting tumours from attack by tumour-associated antigen-specific host cytotoxic T cells. The gene discussed is IDO1; the disease is neoplasm.